For personal use only

Market Announcement
8 July 2020

Recce Pharmaceuticals Ltd (ASX: RCE) – Suspension from
Official Quotation
Description
The securities of Recce Pharmaceuticals Ltd (‘RCE’) will be suspended from quotation immediately under Listing
Rule 17.2, at the request of RCE, pending the release of an announcement regarding a material research
agreement.

Issued by
Vanessa Nevjestic
Adviser, Listings Compliance (Perth)

8 July 2020
ASX Limited

Market Announcement 1/1
ASX Customer Service Centre 131 279 | asx.com.au

For personal use only

8 July 2020
Sean Maloney
Adviser, Listings Compliance (Perth)
Level 40 Central Park
152 - 158 St George’s Terrace
PERTH WA 6000
By email:

tradinghaltsperth@asx.com.au

Dear Sean

Recce Pharmaceuticals Ltd (ASX:RCE) – Voluntary Suspension request
Pursuant to ASX Listing Rule 17.2, Recce Pharmaceuticals Ltd ACN 124 849 065 (Company)
requests for its securities to be voluntarily suspended pending the release of an announcement
relating to a Material Research Agreement.
The Company requests that the voluntary suspension be effective immediately and remain in place
until the earlier of the commencement of normal trading on Thursday, 9 July 2020 or the release of
an announcement by the Company in relation to a Material Research Agreement.
The Company is not aware of any reason why the voluntary suspension should not be granted.
For any questions, please contact the undersigned on +61 2 8072 1400.
Yours faithfully

Alistair McKeough
Company Secretary

